Related Experiment Video
Updated: Jan 1, 2026

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
Published on: May 26, 2023
Metal Bioavailability Models: Current Status, Lessons Learned, Considerations for Regulatory Use, and the Path
Christopher A Mebane1, M Jasim Chowdhury2, Karel A C De Schamphelaere3
1US Geological Survey, Boise, Idaho.
Biotic ligand models are key for assessing aquatic metal risks. This review critically examines their mechanistic basis, application in environmental standards, and suggests improvements for accuracy, especially regarding pH and temperature effects.
Area of Science:
- Environmental Chemistry
- Ecotoxicology
- Risk Assessment
Background:
- Biotic ligand models (BLMs) dominate metal risk assessment in aquatic environments.
- These models link metal bioavailability to toxicity.
- Critical review needed for model refinement and regulatory application.
Purpose of the Study:
- Critically evaluate the mechanistic evidence for metal bioavailability models.
- Assess considerations for using and refining toxicity models.
- Examine incorporating these models into environmental quality standards.
- Provide recommendations for developing and applying metal bioavailability models.
Main Methods:
- Literature review and critical analysis of existing evidence.
- Evaluation of mechanistic approaches in bioavailability modeling.
- Assessment of model applicability in regulatory frameworks.
- Synthesis of recommendations for model development and use.
Main Results:
- Models struggle with pH effects due to multiple mechanisms.
- Differentiates between algae/plant and animal models; animal models often interchangeable, but aquatic insects may differ.
- Recommends equilibrium conditions and dietary exposure in testing.
- Identifies temperature and phosphate as key unaddressed toxicity modifiers.
- Acclimation can influence model predictions.
Conclusions:
- Refining metal bioavailability models requires addressing pH, temperature, and dietary factors.
- Distinguishing between organism groups (e.g., plants vs. animals) is crucial.
- Empirical tools should complement mechanistic models.
- Public availability and ongoing support are essential for regulatory use.
More Related Videos
08:25Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
08:46Dose Uptake of Platinum- and Ruthenium-based Compound Exposure in Zebrafish by Inductively Coupled Plasma Mass Spectrometry with Broader Applications
Published on: April 21, 2022
Related Concept Videos
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability: Overview
Bioavailability: Overview
Bioavailability Study Design: Single Versus Multiple Dose Studies
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.